United Therapeutics (UTHR) Interest Coverage Ratio Growth (3y) (2012 - 2026)
United Therapeutics (UTHR) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 41.72% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 182.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.01% |
| Dec 31, 2025 | 100.50% |
| Sep 30, 2025 | -19.74% |
| Jun 30, 2025 | 23.88% |
| Mar 31, 2025 | -16.25% |
| Dec 31, 2024 | 23.94% |
| Sep 30, 2024 | -19.03% |
| Jun 30, 2024 | -17.95% |
| Mar 31, 2024 | 72.55% |
| Dec 31, 2023 | 22.10% |
| Sep 30, 2023 | -76.54% |
| Jun 30, 2023 | -47.90% |
| Mar 31, 2023 | -64.13% |
| Dec 31, 2022 | 31.00% |
| Sep 30, 2022 | -67.42% |
| Jun 30, 2022 | -75.64% |
| Mar 31, 2022 | 26.24% |
| Dec 31, 2021 | 5.71% |
| Sep 30, 2021 | -32.86% |
| Jun 30, 2021 | -54.01% |